Back to Menu
A pituitary adenoma originates from the anterior or posterior pituitary, and the vast majority are benign. Clinical manifestations are mainly due to endocrine dysregulation from excessive hormone secretion or due to compression of surrounding structures such as the pituitary gland itself and the optic chiasm.
1. Classification by size
Microadenomas are <1 cm in diameter, whereas macroadenomas are ≥1 cm, with the latter more likely to cause compressive symptoms.
2. Classification by hormonal function
Functioning adenomas secrete biologically active hormones, including prolactinomas and growth hormone–secreting adenomas; nonfunctioning adenomas do not secrete active hormones.
3. Classification by pathology and molecular features
Tumor type is determined by cell lineage and hormone immunostaining. Transcription factor–based classification enables more precise subtyping; invasive tumors are considered special entities.
1. Genetic factors
Most cases are sporadic. A minority are associated with hereditary syndromes such as MEN1 and AIP mutations, leading to familial pituitary adenomas.
2. Somatic genetic mutations
Acquired mutations in pituitary cells, such as GNAS and USP8, drive clonal proliferation and represent a core mechanism.
3. Hypothalamic regulatory abnormalities
Excess hypothalamic hormone secretion may promote pituitary hyperplasia and subsequent tumor formation, although this hypothesis remains debated.
4. Other factors
Estrogen may promote lactotroph hyperplasia. Associations with head trauma and viral infection have not been clearly established.
1. Regular examinations and vigilance for symptoms
Pay attention to menstrual irregularities, changes in appearance, headache, and visual deterioration, and undergo periodic hormonal testing and MRI when indicated.
2. Healthy lifestyle
Maintain balanced nutrition, moderate exercise, and a healthy body weight, and avoid inappropriate use of hormonal medications.
3. Standardized treatment and long-term follow-up
Adhere to medical recommendations and maintain lifelong follow-up to monitor hormonal status and imaging changes.
4. Psychological support and patient education
Patients should receive psychological support and education to facilitate adherence to treatment and long-term management.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the dual harm of pituitary adenomas: endocrine abnormalities can cause infertility and cardiovascular or cerebrovascular disease, and mass effect can result in permanent vision loss. Coordinated care between endocrinology and neurosurgery is essential. Early hormonal screening and MRI are pivotal, and individualized treatment with lifelong follow-up results in favorable outcomes for most patients.
A pituitary adenoma originates from the anterior or posterior pituitary, and the vast majority are benign. Clinical manifestations are mainly due to endocrine dysregulation from excessive hormone secretion or due to compression of surrounding structures such as the pituitary gland itself and the optic chiasm.
1. Classification by size
Microadenomas are <1 cm in diameter, whereas macroadenomas are ≥1 cm, with the latter more likely to cause compressive symptoms.
2. Classification by hormonal function
Functioning adenomas secrete biologically active hormones, including prolactinomas and growth hormone–secreting adenomas; nonfunctioning adenomas do not secrete active hormones.
3. Classification by pathology and molecular features
Tumor type is determined by cell lineage and hormone immunostaining. Transcription factor–based classification enables more precise subtyping; invasive tumors are considered special entities.
1. Genetic factors
Most cases are sporadic. A minority are associated with hereditary syndromes such as MEN1 and AIP mutations, leading to familial pituitary adenomas.
2. Somatic genetic mutations
Acquired mutations in pituitary cells, such as GNAS and USP8, drive clonal proliferation and represent a core mechanism.
3. Hypothalamic regulatory abnormalities
Excess hypothalamic hormone secretion may promote pituitary hyperplasia and subsequent tumor formation, although this hypothesis remains debated.
4. Other factors
Estrogen may promote lactotroph hyperplasia. Associations with head trauma and viral infection have not been clearly established.
1. Regular examinations and vigilance for symptoms
Pay attention to menstrual irregularities, changes in appearance, headache, and visual deterioration, and undergo periodic hormonal testing and MRI when indicated.
2. Healthy lifestyle
Maintain balanced nutrition, moderate exercise, and a healthy body weight, and avoid inappropriate use of hormonal medications.
3. Standardized treatment and long-term follow-up
Adhere to medical recommendations and maintain lifelong follow-up to monitor hormonal status and imaging changes.
4. Psychological support and patient education
Patients should receive psychological support and education to facilitate adherence to treatment and long-term management.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the dual harm of pituitary adenomas: endocrine abnormalities can cause infertility and cardiovascular or cerebrovascular disease, and mass effect can result in permanent vision loss. Coordinated care between endocrinology and neurosurgery is essential. Early hormonal screening and MRI are pivotal, and individualized treatment with lifelong follow-up results in favorable outcomes for most patients.